One Analyst Said SpaceX Has "Significant Moats" and Just Put a Buy Rating on the Stock. Is He Right?

SpaceX has a strong launch position, with 161 launches in 2025 and more than 80% of U.S. commercial launches, while Starlink has 12 million global subscribers. However, the article argues against buying the stock at current levels: first-half 2026 capex rose 309% to $28.5 billion, more than 80% directed to AI, while that segment generated $3.4 billion in revenue; shares trade at 68 times sales versus a technology-sector average below 8. Barclays initiated coverage with a buy rating and a $254 target, implying 56% upside, but the author emphasizes high spending, valuation, and lack of net profitability.

Analysis

The key valuation risk is not simply elevated investment; it is whether investors are pricing several distinct options—launch, Starlink, mobile service and orbital compute—as if each will scale successfully. Those businesses have different capital needs, timelines and regulatory dependencies. The reported AI spend/revenue comparison is a warning, not proof of poor returns: revenue is not profit, and the figures provided do not establish segment cash flow, asset lives or how much infrastructure benefits other SpaceX businesses. Verify those before treating the capex as value destruction.

Near term, the premium leaves SPCX exposed to a multiple reset if spending stays elevated while monetization milestones slip. But an outright short is hazardous: launch capacity and Starlink create strategic value, and a credible deployment milestone could reprice the long-dated options quickly. Over 1–3 months, watch for capex cadence, segment economics and evidence that spectrum can support a commercially viable mobile product; spectrum ownership alone does not establish coverage, handset compatibility or regulatory clearance. Over 6–18 months, orbital-compute economics depend on launch cost, power, thermal management, replacement cycles and customer demand—not launch capability alone.

RKLB is not an automatic hedge or beneficiary: cheaper, more frequent launches could expand the market, but SpaceX scale and potential cost reductions could also intensify pricing pressure. Alphabet’s in-orbit test is validation of interest, not evidence yet of material earnings contribution. The contrarian point is that capex may be rational if shared infrastructure compounds across businesses; the missing evidence is returns on invested capital and segment-level cash generation.

Key Decisions for Investors

• SPCX: avoid adding solely on the analyst upgrade; treat the valuation as requiring execution across multiple businesses. Reassess after the next financial disclosure for capex trajectory, segment-level cash generation and Starlink subscriber economics.
• If SPCX options are sufficiently liquid, consider a small, defined-risk put spread only if elevated investment persists without measurable monetization progress; avoid an unhedged short given launch/Starlink optionality and squeeze risk. The bearish thesis is weakened by capex deceleration alongside improving service cash generation or tangible mobile/orbital-compute commercialization.
• Do not buy RKLB as a simple SpaceX countertrade. Watch launch pricing, backlog conversion and gross-margin direction: improving demand with stable economics would support a separate long thesis; evidence of price pressure or weaker conversion would argue against it.